Your browser doesn't support javascript.
loading
Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2.
Jordan, Justin T; Orr, Christina C; Thalheimer, Raquel D; Cambillo, Josephine V; Beauchamp, Roberta L; Shaikh, Ghalib; Muzikansky, Alona; Stemmer-Rachamimov, Anat; Giovannini, Marco; Kalamarides, Michel; Barker, Fred G; Ramesh, Vijaya; Plotkin, Scott R.
Afiliação
  • Jordan JT; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Orr CC; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Thalheimer RD; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Cambillo JV; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Beauchamp RL; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Shaikh G; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Muzikansky A; Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Stemmer-Rachamimov A; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Giovannini M; Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA and Jonsson Comprehensive Cancer Center (JCCC), University of California Los Angeles, Los Angeles, CA, USA.
  • Kalamarides M; Department of Neurosurgery, Hopital Pitie-Salpetriere, Sorbonne Université, Paris, France.
  • Barker FG; Neurosurgical Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Ramesh V; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Plotkin SR; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Neurooncol Adv ; 5(1): vdad041, 2023.
Article em En | MEDLINE | ID: mdl-37215956
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Neurooncol Adv Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Neurooncol Adv Ano de publicação: 2023 Tipo de documento: Article